Аңдатпа
Oncological patientsare more susceptible to various infections, including coronovirus infection, due to their systemic immunosuppressive state caused by the disease itself and the anticancer therapy received. The study of the impact of the past pandemic on the main oncological indicators is an urgent issue that will allow you to effectively plan the activities of the oncological service.The purpose of the study is to study the impact of the COVID-19 pandemic on morbidity and mortality rates from cancer in the population of Kazakhstan.Methods. A retrospective comparison was made of the statistical data on the health of the population of the Republic of Kazakhstan in the period from 2018 to 2020. The data was taken from an open source - the National Scientific Center for Health Development named after Salidat Kairbekova. Morbidity and mortality rates from oncological diseases per 100.000 population were analyzed.Results. Mortality from cancer in Kazakhstan in 2018 was 96.53 0/0000, in 2019 - 93.180/0000, and in 2020 - 80.7 0/0000. The indicators of oncological morbidity of the population registered in the country's medical institutions were as follows: 2251.70/0000 - for 2018, 23330/0000 for 2019 and 2287.80/0000 for 2020.Conclusions. The relationship between morbidity and mortality from cancer and the incidence of COVID-19 is not statistically significant.Key words: COVID-19, cancer incidence, cancer mortality, Kazakhstan.